Atlanta company GeoVax raises more money for Covid-19 vaccine, cancer treatment trials


The $20 million will be used to accelerate three ongoing clinical trials by the company for Covid-19 vaccines and cancer treatments. In January, GeoVax raised $10 million for the same clinical trials.

Previous Florida targets pharmacy benefit managers
Next Highmark and Google Cloud expand data analytics, transforming patient and clinician experiences